参考文献/References:
[1]Assady S,Wanner N,Skorecki KL,et al.New Insights into Podocyte Biology in Glomerular Health and Disease[J].J Am Soc Nephrol,2017,28(6):1707-1715.
[2]Nagata M.Podocyte injury and its consequences[J].Kidney Int,2016,89(6):1221-1230.
[3]Bose M,Almas S,Prabhakar S.Wnt signaling and podocyte dysfunction in diabetic nephropathy[J].J Investig Med,2017,65(8):1093-1101.
[4]Sakhi H,Moktefi A,Bouachi K,et al.Podocyte Injury in Lupus Nephritis[J].J Clin Med,2019,8(9):1340.
[5]Yoshimura Y,Nishinakamura R.Podocyte development, disease, and stem cell research[J].Kidney Int,2019(19):590-593.
[6]Torban E,Braun F,Wanner N,et al.From podocyte biology to novel cures for glomerular disease[J].Kidney Int,2019(19):583-589.
[7]Lu CC,Wang GH,Lu J,et al.Role of Podocyte Injury in Glomerulosclerosis[J].Adv Exp Med Biol,2019(1165):195-232.
[8]Szrejder M,Piwkowska A.AMPK signalling:Implications for podocyte biology in diabetic nephropathy[J].Biol Cell,2019,111(5):109-120.
[9]Chebotareva NV,Bobkova IN,Lysenko LV.The role of podocytes dysfunction in chronic glomerulonephritis progression[J].Ter Arkh,2018,90(6):92-97.
[10]Doublier S,Salvidio G,Lupia E,et al.Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensinⅡ[J].Diabetes,2003,52(4):1023-1030.
[11]Jin J,Gong J,Zhao L,et al.Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux[J].J Diabetes,2019,11(10):826-836.
[12]Wang X,Gao Y,Tian N,et al.Astragaloside IV inhibits glucose-induced epithelial-mesenchymal transition of podocytes through autophagy enhancement via the SIRT-NF-κB p65 axis[J].Sci Rep,2019,9(1):323.
[13]Ling L,Chen L,Zhang C,et al.High glucose induces podocyte epithelial to mesenchymal transition by demethylation mediated enhancement of MMP9 expression[J].Mol Med Rep,2018,17(4):5642-5651.
[14]Fuchshofer R,Ullmann S,Zeilbeck LF,et al.Connective tissue growth factor modulates podocyte actin cytoskeleton and extracellular matrix synthesis and is induced in podocytes upon injury[J].Histochem Cell Biol,2011,136(3):301-319.
[15]Perysinaki GS,Moysiadis DK,Bertsias G,et al.Podocyte mainslit diaphragm proteins nephrin and podocin, are affected at early stages of lupus nephritis and correlate with disease histology[J].Lupus,2011,20(8):781-791.
[16]Chang YP,Sun B,Han Z,et al.Saxagliptin Attenuates Albuminuria by Inhibiting Podocyte Epithelial- to-Mesenchymal Transition via SDF-1α in Diabetic Nephropathy[J]. Front Pharmacol,2017(8):780.
[17]Gui T,Sun Y,Shimokado A,et al.The Roles of Mitogen -Activated Protein Kinase Pathways in TGF -beta -Induced Epithelial -Mesenchymal Transition[J].J Signal Transduct,2012(2012):289243.
[18]李静,柳斌,樊均明.TGF-β在足细胞生理功能及病理损伤中的作用[J].中国中西医结合肾病杂志,2011,12(12):1120-1122.
[19]Gil D,Ciolczyk-Wierzbicka D,Dulinska-Litewka J,et al.Themechanism of contribution of integrin linked kinase (ILK) to epithelial-mesenchymal transition (EMT)[J].Adv Enzyme Regul,2011,51(1):195-207.
[20]Lin CL,Wang JY,et al.Wnt/β-catenin signaling modulates survival of high glucose-stressed mesangial cells[J].Journal of the American.society of Nephrology,2006,17(10):2812-2820.
[21]Wu X,Gao Y,Xu L,et al.Exosomes from high glucose-treated glomerular endothelial cells trigger the epithelial-mesenchymal transition and dysfunction of podocytes[J].Sci Rep,2017,7(1):9371.
[22]Zhou T,He X,Cheng R,et al.Implication of dysregulation of the canonical wingless-type MMTV integration site (WNT) pathway in diabetic nephropathy[J].Diabetologia,2012,55(1):255-266.
[23]Feng Y,Ren J,Gui Y,et al.Wnt/β-Catenin-Promoted Macrophage Alternative Activation Contributes to Kidney Fibrosis[J].J Am Soc Nephrol,2018,29(1):182-193.
[24]Shi G,Wu W,Wan YG,et al.Low dose of triptolide ameliorates podocyte epithelial-mesenchymal transition induced by high dose of D-glucose via inhibiting Wnt3α/β-catenin signaling pathway activation[J].China Journal of Chinese Materia Medica,2018,43(1):139-146.
[25]Dai C,Stolz DB,et al.Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria[J].J Am Soc Nephrol,2009,20(9):1997-2008.